DaShenLin Pharmaceutical Group Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 4,059.026 million compared to CNY 3,362.201 million a year ago. Operating income was CNY 456.742 million compared to CNY 388.626 million a year ago. Net income was CNY 340.552 million compared to CNY 280.268 million a year ago. Basic earnings per share from continuing operations was CNY 0.52 compared to CNY 0.43 a year ago.